Literature DB >> 9557922

Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension.

F Lacy1, D T O'Connor, G W Schmid-Schönbein.   

Abstract

BACKGROUND: Oxygen free radicals may play roles in hypertension both in arteriolar constriction and in formation of lesions.
OBJECTIVE: To quantify free radical production in blood plasma of genetic hypertensives.
DESIGN: Hydrogen peroxide levels were measured, because it is one of the most stable reactive oxygen species.
METHODS: An electrode technique was used to determine plasma hydrogen peroxide levels after blockade of endogenous catalase with sodium azide. This method was validated by an independent spectrophotometric technique.
RESULTS: Members of the essential hypertensive group (n=21) had higher plasma hydrogen peroxide levels (3.16+/-0.14 versus 2.50+/-0.16 micromol/l, P=0.005) than did members of the normotensive group (n=29). Furthermore, within the normotensive group, those with a family history of hypertension (n=15) exhibited higher hydrogen peroxide levels (2.83+/-0.27 versus 2.14< or =0.13 micromol/l, P=0.03) than did those without such a family history (n=14). Plasma hydrogen peroxide levels in these 50 subjects were correlated to their mean arterial pressures (r=0.54, P < 0.001). When hypertensives were grouped with normotensives without a family history of hypertension, the correlation improved (r=0.70, P< 0.001). Statistical analysis (two-way analysis of variance) revealed that a family history of hypertension was a better predictor of plasma hydrogen peroxide production than was blood pressure status (P=0.003 versus P=0.093). Further investigations showed that superoxide is produced in plasma and that one of its sources is xanthine oxidase.
CONCLUSIONS: Hydrogen peroxide is produced in blood plasma and elevation of its level could constitute a pathogenic factor in vascular organ damage attendant upon systemic hypertension.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557922     DOI: 10.1097/00004872-199816030-00006

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  67 in total

Review 1.  Heredity and the autonomic nervous system in human hypertension.

Authors:  D T O'Connor; P A Insel; M G Ziegler; V Y Hook; D W Smith; B A Hamilton; P W Taylor; R J Parmer
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

Review 2.  How long should telomeres be?

Authors:  A Aviv; C B Harley
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

3.  Characteristics of reactive oxygen metabolites in serum of early teenagers in Japan.

Authors:  Terumi Kogawa; Miya Nishimura; Shizuka Kurauchi; Ikuo Kashiwakura
Journal:  Environ Health Prev Med       Date:  2011-12-30       Impact factor: 3.674

4.  Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria.

Authors:  Paul M O'Connor; David D Gutterman
Journal:  Circ Res       Date:  2010-07-09       Impact factor: 17.367

5.  Matrix metalloproteinases activities in hypertension: emerging opportunities.

Authors:  Geert W Schmid-Schönbein
Journal:  Hypertension       Date:  2010-11-15       Impact factor: 10.190

6.  Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene.

Authors:  Jiaur R Gayen; Kuixing Zhang; Satish P RamachandraRao; Manjula Mahata; Yuqing Chen; Hyung-Suk Kim; Robert K Naviaux; Kumar Sharma; Sushil K Mahata; Daniel T O'Connor
Journal:  Circ Cardiovasc Genet       Date:  2010-08-20

7.  Pseudomonas aeruginosa OxyR is required for full virulence in rodent and insect models of infection and for resistance to human neutrophils.

Authors:  Gee W Lau; Bradley E Britigan; Daniel J Hassett
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

8.  Garlic supplementation prevents oxidative DNA damage in essential hypertension.

Authors:  Veena Dhawan; Sanjay Jain
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

9.  Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats.

Authors:  J Duarte; R Pérez-Palencia; F Vargas; M A Ocete; F Pérez-Vizcaino; A Zarzuelo; J Tamargo
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

10.  Nutritional prevention on hypertension, cerebral hemodynamics and thrombosis in stroke-prone spontaneously hypertensive rats.

Authors:  Takanori Noguchi; Katsumi Ikeda; Yasuto Sasaki; Yukio Yamori
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.